Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITYCheck your eligibility now & get in touch with a study center
CHECK ELIGIBILITYCheck your eligibility now & get in touch with a study center
CHECK ELIGIBILITYCheck your eligibility now & get in touch with a study center
CHECK ELIGIBILITYCheck your eligibility now & get in touch with a study center
CHECK ELIGIBILITYHave you or your child been recently diagnosed
with type 1 diabetes?
Type 1 diabetes (T1D) happens when the body's immune system (the body’s natural defence) accidentally destroys the cells that make insulin in the pancreas (beta cells). As a result, insulin production becomes low and therefore sugar in the blood gets too high. People often find out they have T1D when they start to:
People with type 1 diabetes need to take insulin every day for the rest of their lives. This helps keep their blood sugar at the right level.
Very often, type 1 diabetes starts many years before symptoms appear and a patient is diagnosed. People may not have any signs of disease until most of their beta cells are no longer making insulin.
After being diagnosed with Type 1 Diabetes (T1D), some people experience what doctors call a "honeymoon period." During this time, your body might still make some insulin on its own. This can mean you might need fewer insulin shots and find it easier to manage your blood sugar levels. Doctors are looking into ways to make this honeymoon period last longer, as it could be helpful for people living with T1D.
The study medication is a special form of protein that is expected to be able to prevent the immune system from destroying cells that produce insulin. Now, scientists can make these proteins in the laboratory to help treat many illnesses. This protein may save the insulin producing cells in the pancreas.
There is a chance that you will receive placebo. A placebo looks like the medicine being tested and is also given in the same way as the medication that is being studied, but it does not have any medicine in it.
If you are already on insulin, this will be continued.
Sanofi is currently conducting 3 different clinical studies aiming to preserve function of insulin producing cells in participants with a recent diagnosis of Stage 3 of T1D.
Check out if you are eligible for these studies and if there are participating site(s) near you.
There is no cost to participate. All study-related exams, medications and medical care are provided. There is no insurance required to take part in this study. You may be compensated for expense and travel.
Sanofi believes that everyone should have the opportunity to take part in clinical trials. It is important to include people who have been historically under-represented in clinical trials. Sanofi is committed to inclusivity in our studies.
If you are interested in learning more about our studies, we encourage you to complete a brief questionnaire to help determine if you may qualify to participate and be referred to a site recruiting in your area for further evaluation.
If you or your child have a recent diagnosis of type 1 diabetes, you can complete this questionnaire for yourself or your child. Please answer accordingly.
The prescreener preview is complete. You may now close the preview.
Version 1.0, Approved 04/2025
Images property of Sanofi